ABSTRACT
Genetic blocks in the catabolism of cholesterol-rich lipoproteins are important causes of hypercholesterolemia and atherosclerosis in humans. The prototypic diseases are familial hypercholesterolemia, caused by a defect in the low density lipoprotein receptor (LDLR) (1) , and familial type III hyperlipoproteinemia, caused by a defect in one of the ligands for this receptor, apolipoprotein E (apoE) (2) .
To create murine models for these diseases, the laboratories of Maeda (3) and Breslow (4) used the technique of homologous recombination in embryonic stem cells to produce strains of mice lacking apoE. Ishibashi et al. (5, 6) used the same technology to inactivate the gene for the LDLR. Homozygous apoE(-/-) mice and LDLR(-/-) mice exhibited hypercholesterolemia, but the severity and manifestations differed markedly. On a normal chow diet, the apoE(-/-) mice had much more profound hypercholesterolemia (plasma cholesterol, =600 mg/dl) (3, 4) as compared with the LDLR(-/-) mice (=250 mg/dl) (5) . Moreover, the distribution of the cholesterol differed. In the apoE(-/-) mice, cholesterol accumulated primarily in large lipoprotein particles with a size corresponding to chylomicron remnants, very low density lipoproteins (VLDLs), and intermediate density lipoproteins (IDLs) (3, 4) . In contrast, the LDLR(-/-) mice had a much more selective elevation in LDL (5, 6) . The apoE(-/-) mice (3, 4) and the LDLR(-/-) mice (5, 6) both exhibited a profound hyperresponsiveness to dietary cholesterol, with plasma cholesterol levels rising above 2000 mg/dl.
The differences between the two mutant strains of mice are consistent with current models of the differing roles of apoE and the LDLR in the metabolism of cholesterol-rich lipoproteins (1, 2) . These lipoproteins enter the circulation either from the intestine (chylomicrons) or the liver (VLDL). They are partially metabolized by lipoprotein lipase, generating remnant particles known as chylomicron remnants and IDLs, respectively, that are cleared by binding to receptors in the liver.
The bulk of IDL particles are cleared by the liver via the LDLR. When the LDLR is defective, as in familial hypercholesterolemia homozygotes or WHHL rabbits, the IDLs remain in the circulation where they are converted to LDLs (1, 7, 8) . IDLs contain two apolipoproteins capable ofbinding to the LDLR. These are apoE, which binds with high affinity, and apoB-100, which binds with lower affinity (9, 10) . Genetic evidence indicates that apoE is more important in the clearance of IDLs. Thus, in humans with defective apoE, IDLs accumulate in the circulation despite the normal content of apoB-100 (2). In contrast, humans with defective apoB-100 accumulate LDL but not IDL (11) .
The clearance of chylomicron remnants is more complex. These particles contain apoB-48, which lacks the C-terminal half of apoB-100 and cannot bind to LDLRs. Hence, clearance of chylomicron remnants is dependent almost entirely on apoE (10) . Under normal circumstances, many chylomicron remnants are cleared by the LDLR. However, chylomicron remnants do not accumulate in familial hypercholesterolemia homozygotes (1, 12) or WHHL rabbits (13), indicating that the liver has a backup system capable of clearing these particles when the LDLR is absent. This backup system must also rely on apoE since chylomicron remnants accumulate in type III hyperlipoproteinemic patients with defective apoE (2) . Recent evidence suggests that this backup clearance is mediated by the LDLR-related protein (LRP), which binds apoE-enriched remnant particles (14, 15) . LRP may act in concert with proteoglycans on the surface of hepatocytes (16 Lipoprotein metabolism in mice differs importantly from that in humans and rabbits in that 70% of the VLDL particles produced in the mouse liver contain apoB-48 rather than apoB-100 (17) . Thus (18) , the level of plasma apoB-48 should be higher in apoE-deficient mice than in LDLR-deficient mice. In contrast, LDLR-deficient mice should have an isolated elevation in apoB-100. In an animal with a simultaneous deficiency of apoE and the LDLR, apoB-48 and apoB-100 should both accumulate.
In (5) . Total cholesterol content of liver was measured as described (19) except that the blood remaining in the liver was removed by flushing the portal vein with 0.15 M NaCl before taking samples.
Mice. LDLR "knockout" mice, LDLR(-/-) (5), and apoE knockout mice, apoE(-/-) (3), were created by targeted gene disruption as described in the indicated references. To obtain knockout mice that are homozygous for disruption ofboth the LDLR and apoE loci, male apoE(+/-) mice were mated to female LDLR(-/-) mice. The resulting apoE(+/-); LDLR(+/-) mice were identified by Southern blot analysis and bred to each other to produce apoE(-/-); born and raised in a single environment in Dallas and fed a normal chow diet. As reported previously (3-5), plasma cholesterol levels in the apoE(-/-) mice (mean, 579 mg/dl) were much higher than those in the LDLR(-/-) mice (mean, 268 mg/dl). Cholesterol levels in the double homozygotes [apoE(-/-); LDLR(-/-)] were not significantly different from the levels in the apoE(-/-) mice (620 mg/dl). The plasma triglyceride levels in a random sample of nonfasting mice from the four genotypes (8-17 animals per group) on a chow diet were as follows: wild-type mice (89 ± 6 mg/dl; mean ± SE), LDLR(-/-) (149 ± 17), apoE(-/-) (180 ± 32), and apoE(-/-); LDLR(-/-) (176 ± 48).
When wild-type mice were fed a diet containing 1.25% cholesterol plus cholic acid, saturated fat, and casein (1.25% cholesterol/atherogenic diet), the plasma cholesterol level increased only slightly ( Fig. 2A) . In the LDLR(-/-) mice, the plasma cholesterol increased dramatically within 2 weeks, and this was sustained for 8 weeks. The apoE(-/-) mice also showed a dramatic response to cholesterol feeding, as did the apoE(-/-); LDLR(-/-) double homozygotes.
Analysis of plasma lipoproteins by FPLC gel filtration revealed that the LDLR(-/-) mice on a chow diet had the expected peak in the size range ofLDL (Fig. 2B ). When these animals were fed the 1.25% cholesterol/atherogenic diet, there was a marked accumulation of larger lipoproteins, whose size corresponded to chylomicron remnants, VLDLs, and IDLs. In the apoE(-/-) mice on a normal chow diet, most of the cholesterol was contained in lipoproteins corresponding to chylomicron remnants, VLDLs, and IDLs. The 1.25% cholesterol/atherogenic diet elevated all of these lipoproteins, but it preserved the relative size distribution. The apoE(-/-); LDLR(-/-) mice on a normal chow diet showed an elevation in chylomicron remnants, VLDLs, and IDLs and a separate peak indicating an elevation of lipoproteins in the size range of LDLs. When these animals were fed the 1.25% cholesterol/atherogenic diet, all of these lipoproteins were increased in amount. For purposes of quantification, we arbitrarily pooled fractions from the FPLC and classified them as chylomicron/VLDL, IDL/LDL, and high density lipoprotein. The largest increase in cholesterol content was seen in the chylomicron/VLDL fraction of all three Male mice with the indicated genotype (n = 5) were fed a normal chow diet (o) for 9 weeks, and female mice with the indicated genotype (n = 5) were fed a 1.25% cholesterol/atherogenic diet (o) for 9 weeks. Pooled plasma from each group (nonfasting) was centrifiged at d = 1.215 g/ml, the lipoprotein fractions (d < 1.215 g/ml) were subjected to gel filtration on FPLC, and the cholesterol content of each fraction was measured as described. Mean age of the mice at the time of the experiment was 18 weeks. HDL, high density lipoprotein. mutant genotypes fed the cholesterol/atherogenic diet (Table  1) . A lesser but still marked increase occurred in the IDL/ LDL fraction of all three genotypes (Table 1) . Fig. 3 shows the apolipoprotein content of the total pooled lipoprotein fraction from wild-type mice and from mice with the three mutant genotypes fed a normal chow diet and the 1.25% cholesterol/atherogenic diet. On a normal diet, the LDLR(-/-) mice showed a marked increase in the plasma concentration of apoB-100 and a much smaller relative increase in the concentration of apoB-48 (lane 2). The level of apoE was also increased moderately. In contrast, the apoE(-/-) mice showed a selective increase in apoB-48 without an increase in apoB-100 (lane 3). As expected, apoE was absent. In the apoE(-/-); LDLR(-/-) double homozygotes, the levels of apoB-100 and apoB-48 were both elevated (lane 4). When the LDLR(-/-) mice were fed the 1.25% cholesterol/atherogenic diet, the amount of apoB-48 increased markedly, and there was a dramatic increase in the amount of apoE (compare lanes 6 and 2). There was only a slight increase in apoB-100. When the apoE(-/-) animals were fed the cholesterol/atherogenic diet, the major effect was a marked increase in an apolipoprotein whose molecular weight corresponded to that ofapoA-IV (compare lanes 7 and 3). Similar results were observed in the apoE(-/-); LDLR(-/-) double homozygotes (compare lanes 8 and 4) . The identity of the protein designated apoA-IV was confirmed by N-terminal peptide sequencing ofthe protein eluted from the SDS/polyacrylamide gel. Lipoprotein fractions isolated by FPLC in Fig. 2B were used for measurement of total cholesterol content. The following FPLC fractions were pooled for analysis: chylomicron remnants (Chylo)/VLDL, fractions 4-8; IDL/LDL, fractions 9-18; high density lipoprotein (HDL), fractions 19-27. Data are expressed as mg of cholesterol per dl of original plasma sample (before ultracentrifugation). Fig. 2B were isolated by ultracentrifugation, and the delipidated apolipoproteins were subjected to electrophoresis on SDS/5-15% polyacrylamide gradient gels. Proteins were stained with Coomassie blue. The gels were calibrated with Rainbow protein molecular weight marker (Amersham). Positions of migration of apoB-100, apoB-48, apoA-IV, apoE, and apoA-I are denoted.
Cholesterol feeding for 2 weeks increased the cholesterol content of the liver to an approximately equal extent (2-to 4-fold) in wild-type mice and in mice of each of the mutant genotypes (Table 2 ).
DISCUSSION
The current data are consistent with the notion that apoE participates in lipoprotein clearance by binding to two receptors, one of which is the LDLR. Although the nature of the second receptor is not known for certain, for purposes of this discussion we will refer to the second receptor as LRP, which probably acts in concert with hepatic proteoglycans (16) . When LDLRs are deficient, apoE can bind to proteoglycans/LRP, and hence there is no substantial buildup of chylomicron remnants. On the other hand, when apoE is deficient, chylomicron remnants cannot bind to either receptor with high efficiency, and these particles accumulate in plasma.
The two-receptor model of remnant clearance is supported by the observation that the amount of apoB-48 in the plasma lipoproteins of apoE(-/-) mice fed a normal chow diet was severalfold higher than that in the LDLR(-/-) mice (Fig. 3) . If the LDLR were the only molecule involved in the removal of chylomicron remnants, the elevation in apoB-48 should have been similar in the two mouse mutants. Total cholesterol content in liver was measured in female mice with the indicated genotype (n = 3) fed the indicated diet for 15 days. Mean age of mice was 11 weeks at the beginning of the study. Values are means ± SE. The 1.25% cholesterol/atherogenic diet caused a massive increase in the cholesterol content of the chylomicron/VLDL and IDL/LDL fractions in animals of all three genotypes. The relative increase was highest in the LDLR(-/-) animals (100-fold increase in chylomicron/VLDL cholesterol). This is because the LDLR(-/-) animals on a chow diet had much lower levels of chylomicron/VLDL cholesterol as compared with the apoE(-/-) mice and the apoE(-/-); LDLR(-/-) double homozygotes. The 1.25% cholesterol/atherogenic diet also caused a marked increase in the apoB-48 level of the LDLR(-/-) mice (Fig. 3, lane 6) .
Why should the high cholesterol/atherogenic diet cause such a profound elevation in the content of cholesterol and apoB-48 in the chylomicron/VLDL fraction in LDLR(-/-) animals? These animals have abundant apoE. Indeed, the apoE concentration increases markedly on the high cholesterol diet. Why doesn't apoE prevent the hypercholesterolemia by binding to LRP? It seems unlikely that LRP becomes saturated as a result of the overproduction of chylomicron remnants and VLDL on the high cholesterol/atherogenic diet. Abundant amounts of LRP are normally present in the liver. At saturation, LRP should be carrying large amounts of chylomicron remnant particles into the liver, and one would expect that the levels of apoB-48 and cholesterol in the cholesterol-fed LDLR(-/-) mice should be substantially lower than in the cholesterol-fed apoE(-/-); LDLR(-/-) mice in which LRP cannot operate. This was not the case.
A more likely possibility is that the apoE on the chylomicron remnants and VLDL of cholesterol-fed mice is insufficient for clearance through the proteoglycan/LRP complex. Previous data demonstrate that apoE on j3-VLDL particles isolated from cholesterol-fed rabbits is insufficient for binding to LRP. To demonstrate this binding, it is necessary to add additional amounts of exogenous apoE (18) . It is possible that the increased surface area of large cholesterol-rich particles dictates a requirement for increased apoE in order to achieve a high enough local concentration on the particle's surface to permit high-affinity binding to LRP. Although apoE increases in the cholesterol-fed LDLR(-/-) mice, the increase may be insufficient to maintain high-affinity binding to LRP. Previous studies have shown that the C apolipoproteins decrease the binding effectiveness of apoE (20, 21) . We have not yet studied the C apolipoproteins in the mutant mice.
A new finding in this study is the marked increase in lipoprotein-bound apoA-IV in the circulation of the apoE-deficient mice that were fed the high cholesterol/atherogenic diet. The increase was the same whether or not the LDLR was present. ApoA-IV, an apolipoprotein of unknown function, is produced in the intestine and secreted on chylomicrons. The total plasma concentration of apoA-IV is increased by fat feeding in rats (22) and humans (23) . The increase in apoA-IV concentration elicited by the 1.25% cholesterol/atherogenic diet was much greater in the apoE-deficient mice than in the wild-type mice. The functional significance of this observation is obscure, but it may be related to the observation that apoA-IV activates lecithin cholesterol acyltransferase (24) . ApoA-IV may increase in order to enhance cholesterol esterification in the plasma of the cholesterol-overloaded mice. A substantial amount of apoA-IV is normally present in the nonlipoprotein fraction of plasma (23) . We do not yet know whether the total amount of apoA-IV increases in the plasma of the cholesterol-fed apoE(-/-) mice or whether there is a transfer from the nonlipoprotein fraction to particles that are devoid of apoE.
The current study constitutes an initial semiquantitative comparison of the lipoproteins in the apoE(-/-), LDLR(-/-), and apoE(-/-); LDLR(-/-) mice. More extensive and detailed studies of the distribution of the apolipoproteins, including apoA-I, on individual lipopro-tein particles will undoubtedly provide further insights into lipoprotein physiology.
